Literature DB >> 19493683

Lhermitte's sign: Review with special emphasis in oncology practice.

Cengiz Gemici1.   

Abstract

Lhermitte's sign (LS) is characterized by electric shock like sensation, spreading along the spine in a cervico-caudal direction and also into both arms and legs, which is felt upon forward flexion of the neck. It is a myelopathy resulting from damage to sensory axons at the dorsal columns of the cervical or thoracic spinal cord and a well-known clinical sign in neurology practice. Patients with cancer may present with LS due to various causes either related to the tumor itself or to its treatment. Spinal cord tumors, radiotherapy and chemotherapy are possible causes of LS observed in oncology practice. While LS is observed with a frequency of 3.6-13% in large patient groups receiving radiotherapy for head and neck and thoracic malignancies, the true incidence of chemotherapy and spinal cord tumor induced LS is unknown with only few reported cases in the literature. In the present article, various pathologies causing Lhermitte's sign are reviewed with special emphasis on the implications of this sign in oncology practice. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19493683     DOI: 10.1016/j.critrevonc.2009.04.009

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  6 in total

1.  Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms.

Authors:  Daniel Pak; Karen Vineberg; Felix Feng; Randall K Ten Haken; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-26       Impact factor: 7.038

Review 2.  Neurologic Emergencies in the Patients With Cancer.

Authors:  Andrew L Lin; Edward K Avila
Journal:  J Intensive Care Med       Date:  2016-07-09       Impact factor: 3.510

Review 3.  Head and neck cancer survivorship consensus statement from the American Head and Neck Society.

Authors:  Neerav Goyal; Andrew Day; Joel Epstein; Joseph Goodman; Evan Graboyes; Scharukh Jalisi; Ana P Kiess; Jamie A Ku; Matthew C Miller; Aru Panwar; Vijay A Patel; Assuntina Sacco; Vlad Sandulache; Amy M Williams; Daniel Deschler; D Gregory Farwell; Cherie-Ann Nathan; Carole Fakhry; Nishant Agrawal
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-30

4.  Lhermitte Sign as a Presenting Symptom of Thoracic Spinal Pathology: A Case Study.

Authors:  Adam Hills; Mazen Al-Hakim
Journal:  Case Rep Neurol Med       Date:  2015-08-02

5.  Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphoma.

Authors:  Bassem Youssef; JoAnn Shank; Jay P Reddy; Chelsea C Pinnix; George Farha; Mani Akhtari; Pamela K Allen; Michelle A Fanale; John A Garcia; Patricia H Horace; Sarah Milgrom; Grace Li Smith; Yago Nieto; Isadora Arzu; He Wang; Nathan Fowler; Maria Alma Rodriguez; Bouthaina Dabaja
Journal:  Radiat Oncol       Date:  2015-09-25       Impact factor: 3.481

6.  Lhermitte's Sign following VMAT-Based Head and Neck Radiation-Insights into Mechanism.

Authors:  Huaising C Ko; Allison R Powers; Ren-dih Sheu; Sarah L Kerns; Barry S Rosenstein; Stephen C Krieger; Waleed F Mourad; Kenneth S Hu; Vishal Gupta; Richard L Bakst
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.